CPIG
MDGL icon

Chicago Partners Investment Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Chicago Partners Investment Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
981
+204
+26% +$104K 0.01% 963
2026
Q1 		$411K Sell
777
-184
-19% -$87.9K 0.01% 990
2025
Q4 		$462K Sell
961
-64
-6% -$32.7K 0.01% 816
2025
Q3 		$440K Buy
1,025
+56
+6% +$20.9K 0.01% 772
2025
Q2 		$297K Buy
969
+134
+16% +$39.9K 0.01% 845
2025
Q1 		$250K Buy
+835
New +$274K 0.01% 766

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Chicago Partners Investment Group's MDGL Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Madrigal Pharmaceuticals (MDGL) stake by 26% in Q2 2026, buying an estimated $104K and bringing the position to 981 shares worth $533K. The position accounts for 0.01% of the portfolio, ranked #963.

Chicago Partners Investment Group first reported a position in MDGL in Q1 2025 and has held it in 6 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Chicago Partners Investment Group held 981 shares of Madrigal Pharmaceuticals worth $533K as of Q2 2026.
  • Chicago Partners Investment Group bought 204 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $104K.
  • Madrigal Pharmaceuticals made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #963 holding.
  • Chicago Partners Investment Group first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.